Dose Finding Study for Combination Treatment with Topotecan and Gemcitabine of Patients with Recurrent Ovarian Cancer after Failure of First-Line Chemotherapy with Paclitaxel and Platinum

Publisher： Karger

E-ISSN： 2296-5262|27|1|58-64

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.27, Iss.1, 2004-03, pp. : 58-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Sequential Combination of Paclitaxel-Carboplatin and Paclitaxel-Liposomal Doxorubicin as a First-Line Treatment in Patients with Ovarian Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 348-353

Karger

Access to resources Recommend Favorite

Improved Survival Trends in Platinum-Resistant Patients with Advanced Ovarian, Fallopian or Peritoneal Cancer Treated with First-Line Paclitaxel/Platinum Chemotherapy: The Impact of Novel Agents

By  

Oncology, Vol. 84, Iss. 3, 2012-12 ,pp. : 158-165

Karger

Access to resources Recommend Favorite

Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study

By  

Oncology, Vol. 66, Iss. 3, 2004-06 ,pp. : 185-191

Karger

Access to resources Recommend Favorite